Continuous intracerebroventricular administration of a novel dopamine formulation appears safe in Parkinson's disease and may ...

Brett Favre announced his diagnosis on Tuesday. Here’s what we know about the disease and its relationship to head injuries.

Parkinson's disease a common but complex neurodegenerative disorder that affects 10 million people worldwide. Here are some ...

AbbVie plans to share results from another phase 3 trial of tavapadon later this year, the pharma said in the release. That ...

More than a decade after retiring from football, Brett Favre says he has Parkinson’s disease. Favre told a congressional ...

NFL Hall of Famer Brett Favre was recently diagnosed with Parkinson’s disease. The 54-year-old shared the news on Tuesday ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

The Hall of Fame quarterback announced his diagnosis during congressional testimony today. Here's what to know about Parkinson's disease.

A novel drug molecule that activates a key protein in the brain that cleans up and recycles damaged mitochondria may offer ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor impulse control. Now, researchers have identified a ...

Since late 2023, Kaiser has been giving some of its Parkinson’s patients an Apple Watch app called StrivePD, developed by ...